Patterns, risk factors and outcome predictors of posterior reversible encephalopathy syndrome in pediatric cancer patients

References

• Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334(8):494–500.
   PubMed Web of Science ®Google Scholar
• McKinney AM, Short J, Truwit CL, et al. Posterior reversible encephalopathy syndrome: incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol. 2007;189(4):904–912.
   PubMed Web of Science ®Google Scholar
• Siebert E, Spors B, Bohner G, et al. Posterior reversible encephalopathy syndrome in children: radiological and clinical findings – a retrospective analysis of a German tertiary care center. Eur J Paediatr Neurol. 2013;17(2):169–175.
   PubMed Web of Science ®Google Scholar
• de Laat P, Te Winkel ML, Devos AS, et al. Posterior reversible encephalopathy syndrome in childhood cancer. Ann Oncol. 2011;22(2):472–478.
   PubMed Web of Science ®Google Scholar
• Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol. 2017;264(8):1608–1616.
   PubMed Web of Science ®Google Scholar
• Strandgaard S, Paulson OB. Cerebral autoregulation. Stroke. 1984;15(3):413–416.
   PubMedGoogle Scholar
• Siebert E, Bohner G, Liebig T, et al. Factors associated with fatal outcome in posterior reversible encephalopathy syndrome: a retrospective analysis of the Berlin PRES study. J Neurol. 2017;264(2):237–242.
   PubMed Web of Science ®Google Scholar
• Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol. 2008;29(6):1043–1049.
   PubMed Web of Science ®Google Scholar
• Hefzy H, Bartynski W, Boardman J, et al. Hemorrhage in posterior reversible encephalopathy syndrome: imaging and clinical features. AJNR Am J Neuroradiol. 2009;30(7):1371–1379.
   PubMed Web of Science ®Google Scholar
• Benigni A, Morigi M, Perico N, et al. The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance. Transplantation. 1992;54(5):775–780.
   PubMed Web of Science ®Google Scholar
• Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol. 2008;29(6):1036–1042.
   PubMed Web of Science ®Google Scholar
• Tambasco N, Mastrodicasa E, Salvatori C, et al. Prognostic factors in children with PRES and hematologic diseases. Acta Neurol Scand. 2016;134(6):474–483.
   PubMed Web of Science ®Google Scholar
• Noe A, Cappelli B, Biffi A, et al. High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcome. Ital J Pediatr. 2010;36:14.
   PubMed Web of Science ®Google Scholar
• Masetti R, Cordelli DM, Zama D, et al. PRES in children undergoing hematopoietic stem cell or solid organ transplantation. Pediatrics. 2015;135(5):890–901.
   PubMed Web of Science ®Google Scholar
• Fugate JE, Claassen DO, Cloft HJ, et al. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc. 2010;85(5):427–432.
   PubMed Web of Science ®Google Scholar
• Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2007;28(7):1320–1327.
   PubMed Web of Science ®Google Scholar
• Lee MS. Irreversible posterior leukoencephalopathy. Arch Neurol. 2008;65(11):1545. author reply
   PubMedGoogle Scholar
• Alhilali LM, Reynolds AR, Fakhran S. A multi-disciplinary model of risk factors for fatal outcome in posterior reversible encephalopathy syndrome. J Neurol Sci. 2014;347(1-2):59–65.
   PubMed Web of Science ®Google Scholar
• Khan SJ, Arshad AA, Fayyaz MB, et al. Posterior reversible encephalopathy syndrome in pediatric cancer: clinical and radiologic findings. J Glob Oncol. 2018;4:1–8.
   Web of Science ®Google Scholar
• Hinduja A, Habetz K, Raina S, et al. Predictors of poor outcome in patients with posterior reversible encephalopathy syndrome. Int J Neurosci. 2017;127(2):135–144.
   PubMed Web of Science ®Google Scholar
• Schweitzer AD, Parikh NS, Askin G, et al. Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome. Neuroradiology. 2017;59(4):379–386.
   PubMed Web of Science ®Google Scholar
• Legriel S, Schraub O, Azoulay E, et al. Critically III Posterior Reversible Encephalopathy Syndrome Study Group (CYPRESS). Determinants of recovery from severe posterior reversible encephalopathy syndrome. PLoS One. 2012;7(9):e44534. Erratum in: PLoS One. 2013;8(11).
   Google Scholar
• Tetsuka S, Ogawa T. Posterior reversible encephalopathy syndrome: a review with emphasis on neuroimaging characteristics. J Neurol Sci. 2019;404:72–79.
   PubMed Web of Science ®Google Scholar
• Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015;14(9):914–925.
   PubMed Web of Science ®Google Scholar
• Zama D, Gasperini P, Berger M, Supportive Therapy Working Group of Italian Pediatric Haematology and Oncology Association (AIEOP), et al. A survey on hematology-oncology pediatric AIEOP centres: The challenge of posterior reversible encephalopathy syndrome. Eur J Haematol. 2018;100(1):75–82.
   PubMed Web of Science ®Google Scholar
• Khan RB, Sadighi ZS, Zabrowski J, et al. Imaging patterns and outcome of posterior reversible encephalopathy syndrome during childhood cancer treatment. Pediatr Blood Cancer. 2016;63(3):523–526.
   PubMed Web of Science ®Google Scholar
• Çifçi Sunamak E, Özdemir N, Celkan T. Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: experience of a single center using BFM protocols. Pediatr Blood Cancer. 2019;66(6):e27711. Epub 2019 Mar 13.
   PubMed Web of Science ®Google Scholar
• Parikh NS, Schweitzer AD, Young RJ, et al. Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome. J Neurol Sci. 2017;380:11–15. Epub 2017 Jun 29.
   PubMed Web of Science ®Google Scholar
• Abalo-Lojo JM, Baleato-González S, Gonzalez F. Cortical blindness secondary to posterior reversible encephalopathy syndrome, recovered by successful blood pressure management. Arq Bras Oftalmol. 2017;80(5):324–326.
   PubMed Web of Science ®Google Scholar
• Malhotra P, Kapoor G, Jain S, et al. Incidence and risk factors for hypertension during childhood acute lymphoblastic leukemia therapy. Indian Pediatr. 2018;55(10):877–879. Epub 2018 Jul 13.
   PubMed Web of Science ®Google Scholar
• Lo Nigro L, Di Cataldo A, Schiliro G. Acute neurotoxicity in children with B-lineage acute lymphoblastic leukemia (B-ALL) treated with intermediate risk protocols. Med Pediatr Oncol. 2000;35(5):449–455.
   PubMedGoogle Scholar
• Osterlundh G, Bjure J, Lannering B, et al. Studies of cerebral blood flow in children with acute lymphoblastic leukemia: case reports of six children treated with methotrexate examined by single photon emission computed tomography. J Pediatr Hematol Oncol. 1997;19:28–34.
   PubMed Web of Science ®Google Scholar
• Faille LD, Fieuws S, Van Paesschen W. Clinical predictors and differential diagnosis of posterior reversible encephalopathy syndrome. Acta Neurol Belg. 2017;117(2):469–475.
   PubMed Web of Science ®Google Scholar
• Kamiya-Matsuoka C, Paker AM, Chi L, et al. Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study. J Neurooncol. 2016;128(1):75–84.
   PubMed Web of Science ®Google Scholar
• Legriel S, Schraub O, Azoulay E, Critically III Posterior Reversible Encephalopathy Syndrome Study Group (CYPRESS), et al. Determinants of recovery from severe posterior reversible encephalopathy syndrome. PLoS One. 2012;7(9):e44534.
   PubMed Web of Science ®Google Scholar
• Lucchini G, Grioni D, Colombini A, et al. Encephalopathy syndrome in children with hemato-oncological disorders is not always posterior and reversible. Pediatr Blood Cancer. 2008;51(5):629–633.
   PubMed Web of Science ®Google Scholar
• Koksel Y, McKinney AM. Potentially reversible and recognizable acute encephalopathic syndromes: disease categorization and MRI appearances. AJNR Am J Neuroradiol. 2020;41(8):1328–1338.
   PubMed Web of Science ®Google Scholar
• Thavamani A, Umapathi KK, Puliyel M, et al. Epidemiology, comorbidities, and outcomes of posterior reversible encephalopathy syndrome in children in the United States. Pediatr Neurol. 2020;103:21–26.
   PubMed Web of Science ®Google Scholar